Skip to content
PubMed This is a summary of 67 peer-reviewed journal articles Updated
Hematology

Glanzmann Thrombasthenia

At a Glance

Glanzmann Thrombasthenia (GT) is a rare, inherited bleeding disorder where blood platelets lack the specific "hooks" (GPIIb/IIIa receptors) needed to stick together and form clots. Unlike other bleeding disorders, patients with GT have a normal platelet count but their platelets do not function correctly. This leads to prolonged bleeding from the nose, gums, and skin. It is not cancer and can be managed effectively with specialized care.

Receiving a diagnosis of Glanzmann Thrombasthenia (GT) can be overwhelming. You may have been told your platelet count is normal, yet you experience significant bleeding. You might be worried about what this means for your future, your child’s safety, or your daily life.

This guide is designed to help you navigate your journey with GT. It translates complex medical information into clear, actionable knowledge. Here, you will find the tools to understand your body, advocate for the right care, and live fully.

What is Glanzmann Thrombasthenia?

GT is a rare, inherited bleeding disorder. It is not a cancer, and it is not typically life-shortening with proper care [1]. It is a mechanical problem with your blood platelets—the cells responsible for stopping bleeding.

  • The “Plug” Problem: Think of your platelets as bricks and a protein called fibrinogen as the mortar. To build a wall (a clot), the bricks need “hooks” to grab the mortar. In GT, your platelets are missing these hooks (called GPIIb/IIIa receptors) or they don’t work [1][2].
  • The Result: Your body has plenty of platelets (normal count), but they cannot stick together to form a stable clot [3]. This leads to bleeding that is hard to stop, especially from the nose, gums, and skin [4].

How to Use This Guide

We have broken down the information into specific sections to help you find exactly what you need:

Living with GT

Practical advice for school, sports, travel, and managing the emotional impact of a chronic condition.

You Are Not Alone

While GT is rare, you are part of a global community. With the right preparation and a strong care team, you can manage this condition effectively. This guide is your starting point.

Common questions in this guide

What is Glanzmann Thrombasthenia?
Glanzmann Thrombasthenia (GT) is a rare, inherited bleeding disorder. It is caused by a mechanical problem with your blood platelets—the cells responsible for clotting. In GT, platelets are missing specific receptors (or "hooks") needed to stick together and stop bleeding.
Why do I have bleeding symptoms if my platelet count is normal?
People with GT have a normal number of platelets, but those platelets do not function correctly. Because they lack the necessary receptors to bind with fibrinogen (the "mortar" of a clot), they cannot form stable clots to stop bleeding, even though the count appears normal on standard tests.
How is Glanzmann Thrombasthenia diagnosed?
Standard blood tests often overlook GT because they only check the number of platelets, not how well they work. Specialized tests, such as Light Transmission Aggregometry (LTA) and PFA-100, are required to confirm the diagnosis by analyzing platelet function.
Why should platelet transfusions be avoided or used with caution in GT?
Platelet transfusions can sometimes lead to a complication called alloimmunization, where your body develops antibodies against the transfused platelets. This can make future transfusions ineffective. Therefore, doctors often use alternative treatments like recombinant Factor VIIa (rFVIIa) when possible.
Is Glanzmann Thrombasthenia genetic?
GT is passed down through families in an autosomal recessive pattern. This generally means both parents must carry the gene mutation for a child to be born with the condition. It comes in different subtypes (Type I, Type II, and Variant) depending on the severity of the platelet defect.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How can we determine if my bleeding symptoms are due to Type I, Type II, or Variant Glanzmann Thrombasthenia?
  2. 2.What is my current antibody status, and how does that affect my treatment options in an emergency?
  3. 3.Can you provide me with a signed emergency letter that clearly outlines the use of rFVIIa and avoidance of platelet transfusions?
  4. 4.What specific over-the-counter products do you recommend I keep at home for minor bleeds?
  5. 5.Are there any upcoming clinical trials or new therapies for GT that I should be aware of?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (4)
  1. 1

    Hemorrhage of Upper Digestive and Respiratory Tracts in a Child with Glanzmann Thrombasthenia.

    Michali M, Basiari L, Komnos I, et al.

    Maedica 2023; (18(2)):363-367 doi:10.26574/maedica.2023.18.2.363.

    PMID: 37588843
  2. 2

    Stem Cell Transplant in Severe Glanzmann Thrombasthenia in an Adult Patient.

    Ramzi M, Dehghani M, Haghighat S, Nejad HH

    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016; (14(6)):688-690 doi:10.6002/ect.2014.0165.

    PMID: 26134714
  3. 3

    Anesthetic experience for orthopedic surgery on a patient with Glanzmann's thrombasthenia refractory to platelet transfusion: A case report.

    Park JB, Shin YS, Kim SH

    Korean journal of anesthesiology 2009; (57(4)):507-510 doi:10.4097/kjae.2009.57.4.507.

    PMID: 30625914
  4. 4

    Gastrointestinal Bleeding/Angiodysplasia in Patients With Glanzmann Thrombasthenia.

    Tarawah RA, Tarawah AM

    Journal of medical cases 2024; (15(12)):401-405 doi:10.14740/jmc4340.

    PMID: 39610914

This guide provides educational information about Glanzmann Thrombasthenia and is not medical advice. Always consult your hematologist for diagnosis and treatment plans specific to your condition.

Get notified when new evidence is published on Glanzmann Thrombasthenia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.